Concepedia

Maila Dayane Capuchinho de Oliveira

MD

2

Publications

67

Citations

2

H-Index

2022

Active since

Affiliations

Hospital Clínic de Barcelona(Current)

Vall d'Hebron Institute of Oncology

Vall d'Hebron Hospital Universitari

Hospital Clínico Universitario de Valencia

Research Institute Hospital 12 de Octubre

Maila Dayane Capuchinho de Oliveira is an author at Hospital Clínic de Barcelona.

Publications per year

2022–2024

2

Publications

2

A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results

E. Hamilton, Maila Dayane Capuchinho de Oliveira, Nicholas C. Turner et al. · Annals of Oncology · 2024 · 56 citations · Full text

LBA3 Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2- breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial

Aleix Prat, Claudette Falato, Laia Paré Brunet et al. · Annals of Oncology · 2022 · 11 citations · Full text

Rows per page

1–2 of 2